Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 18.15
+0.15 (0.83%)
At close: Jul 10, 2026
Xlife Sciences AG Employees
Xlife Sciences AG had 20 employees as of December 31, 2025. The number of employees increased by 3 or 17.65% compared to the previous year.
Employees
20
Change (1Y)
3
Growth (1Y)
17.65%
Revenue / Employee
13.77K CHF
Profits / Employee
-1.08M CHF
Market Cap
103.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | 3 | 17.65% |
| Dec 31, 2024 | 17 | 0 | - |
| Dec 31, 2023 | 17 | 4 | 30.77% |
| Dec 31, 2022 | 13 | 0 | - |
| Dec 31, 2021 | 13 | 7 | 116.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,595 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 189 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Addex Therapeutics | 3 |